Skip to Main Content

Author Details

Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
1995
94
61
PMIDPaper TitleJournal TitlePublished Year
37377887Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells.Cancer Res Commun2023
37377887Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells.Cancer Res Commun2023
35113651Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.Science2022
35749374Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.Cancer Immunol Res2022
35926468Cancer genes disfavoring T cell immunity identified via integrated systems approach.Cell Rep2022
35113651Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.Science2022
35749374Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.Cancer Immunol Res2022
35926468Cancer genes disfavoring T cell immunity identified via integrated systems approach.Cell Rep2022
34168045Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy.Clin Cancer Res2021
34168045Identification and Validation of T-cell Receptors Targeting <i>RAS</i> Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy.Clin Cancer Res2021
34526724An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemness.Nature2021
34526724An engineered IL-2 partial agonist promotes CD8<sup>+</sup> T cell stemness.Nature2021
32231230Identification of Small Molecule Enhancers of Immunotherapy for Melanoma.Sci Rep2020
31959727Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models.J Immunother Cancer2020
32231230Identification of Small Molecule Enhancers of Immunotherapy for Melanoma.Sci Rep2020
31996390Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens.Clin Cancer Res2020
33303615Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer.Science2020
32516591Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.Cancer Cell2020
31996390Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens.Clin Cancer Res2020
31959727Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models.J Immunother Cancer2020
33303615Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer.Science2020
32516591Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies.Cancer Cell2020
30694219T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.J Clin Invest2019
31628526Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.Cancer Immunol Immunother2019
31092734An effective mouse model for adoptive cancer immunotherapy targeting neoantigens.JCI Insight2019
30923193T cell stemness and dysfunction in tumors are triggered by a common mechanism.Science2019
30694219T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.J Clin Invest2019
31405895Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells.J Exp Med2019
30778251The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunity.Nat Immunol2019
30714987Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.J Clin Invest2019
31405895Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells.J Exp Med2019
31628526Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.Cancer Immunol Immunother2019
30714987Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.J Clin Invest2019
30778251The transcription factor c-Myb regulates CD8<sup>+</sup> T cell stemness and antitumor immunity.Nat Immunol2019
30923193T cell stemness and dysfunction in tumors are triggered by a common mechanism.Science2019
31092734An effective mouse model for adoptive cancer immunotherapy targeting neoantigens.JCI Insight2019
29562175Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System.Cell Rep2018
29669936Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.JCI Insight2018
29562175Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System.Cell Rep2018
29669936Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.JCI Insight2018
27803044Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers.Clin Cancer Res2017
28935813ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.Cancer Res2017
27803044Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers.Clin Cancer Res2017
27965307Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.Clin Cancer Res2017
28935813ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer.Cancer Res2017
27965307Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.Clin Cancer Res2017
26701267Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.Cancer Immunol Res2016
26731475The transcription factor BACH2 promotes tumor immunosuppression.J Clin Invest2016
27271569Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.J Immunol2016
27158840BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers.Nat Immunol2016
  • 1 - 50 of 188

Recommended Authors

Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year 2008
Number of shared co-authors 3
Moutih Rafei
Universite de Montreal
Career Start Year 2007
Number of shared co-authors 0
Andrea Schietinger
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 0
Glenda Canderan
University of Virginia
Career Start Year 2003
Number of shared co-authors 0
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Masaki Terabe
National Cancer Institute
Career Start Year 1997
Number of shared co-authors 6
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Cynthia Perez
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 0
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 10
Alan Melcher
The Institute of Cancer Research
Career Start Year 1994
Number of shared co-authors 0
Claudia Rossig
University Children's Hospital Muenster
Career Start Year 1994
Number of shared co-authors 1
Lawrence Fong
University of California san francisco
Career Start Year 1993
Number of shared co-authors 1
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 4
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year 1991
Number of shared co-authors 3
Drake Laface
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 0
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Career Start Year 1986
Number of shared co-authors 4
David B Weiner
Wistar Institute
Career Start Year 1986
Number of shared co-authors 0
Sandra Demaria
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 3
Elizabeth M Jaffee
Convergence Institute, Johns Hopkins University
Career Start Year 1985
Number of shared co-authors 3
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 0
Peter S Linsley
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 2
Ronald E Gress
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 13
Victor H Engelhard
University of Virginia School of Medicine
Career Start Year 1976
Number of shared co-authors 2
Antoni Ribas
University of California Los Angeles (university of california los angeles)
Career Start Year 1972
Number of shared co-authors 7
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 6
Jay A Berzofsky
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1966
Number of shared co-authors 10
David W Scott
University of British Columbia
Career Start Year 1965
Number of shared co-authors 2
John R Wunderlich
National Cancer Institute
Career Start Year 1963
Number of shared co-authors 12

Collaborators

Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 76
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 41
Rahul Roychoudhuri
Co-authored papers 16
Joseph G Crompton
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 8
Tori N Yamamoto
National Cancer Institute
Co-authored papers 8
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Co-authored papers 5
David S Schrump
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
David F Stroncek
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 4
Satyajit Ray
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Lionel Feigenbaum
Science Applications International Corporation/Frederick
Co-authored papers 4
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Co-authored papers 2
Yasmine Belkaid
National Institute of Allergy and Infectious Diseases
Co-authored papers 2
Brian M Baker
Co-authored papers 2
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Electron Kebebew
Stanford University School of Medicine
Co-authored papers 2
Lisa Zhang
National Institute of Child Health and Development
Co-authored papers 2
William G Telford
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Susan R Davis
Co-authored papers 2
Chi-Chao Chan
National Eye Institute, National Institutes of Health
Co-authored papers 2
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 2
Todd D Prickett
National Cancer Institute
Co-authored papers 2
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Jennifer A Wargo
Co-authored papers 2
Yuka Kanno
Co-authored papers 2
John J O'Shea
National Institute of Arthritis, National Institutes of Health
Co-authored papers 2
Haruhiko Koseki
RIKEN Research Center for Allergy and Immunology
Co-authored papers 1
Vivek Shukla
Chalmers University of Technology
Co-authored papers 1
Jeanette Beers
and Blood Institute, National Institutes of Health
Co-authored papers 1
Yaqin Zhang
Jiangsu University Zhenjiang 212013
Co-authored papers 1
Release 1.2